Market View

The U.S. market is in a Confirmed Uptrend. The S&P 500 and Nasdaq traded lower for most of the week before closing strong on Friday to each end with a slight weekly gain. Support for both indices is at their respective 21-DMA (5,673; 17,840). The distribution day count stands at zero and two, respectively.

Market View

The U.S. market is in a Confirmed Uptrend. Indices continue to consolidate recent gains as the S&P 500 is trading at all-time highs while the Nasdaq is only 3% off its high. The first level of support for both indices is at the 10-DMA (5,696, 17,920) followed by the rising 21-DMA (5,614 ,17,573) . The distribution day count stands at zero and one, respectively.

Market View

The U.S. market has been upgraded to a Confirmed Uptrend from a Rally Attempt. The S&P 500 was up 1.4% for the week, staging a Day 9 follow-through day on Thursday and moving into all-time highs. The Nasdaq rose 1.5% for the week but narrowly missed a follow-through day on Thursday, as volume was a bit lower than the prior day. It is testing the midpoint of a 10-week range (18,018) and remains about 4% off all-time highs. The Nasdaq did pick up a Distribution Day on Friday while the S&P 500 avoided one. Rising 21-DMA support for each index is 2-2.5% below (5,585/17,515).

O’Neil Health Care Weekly

XLV declined 2.1% last week, pulling back from all-time high extended levels. The index is now sitting on 21-DMA ($154) support, with
the 50-DMA ($150) 2.4% lower. Despite the pullback, the RS line is still making higher highs, warranting a continued overweight
sector positioning.

Market View

The U.S. market was shifted to a Downtrend on Friday. The S&P 500 fell over 4% and breached its 50-DMA (5,505) after briefly testing all-time highs in the prior week. It closed 5% off highs with next support <1% lower at the rising 100-DMA (5,379). The Nasdaq fell nearly 6%, breaking through its 50-DMA (17,575) early in the week and its 100-DMA (17,118) on Friday. Next support is 2.5% lower at its rising 200-DMA (16,277). The earliest eligibility for a new follow-through day will now be Thursday, September 12.

O’Neil Health Care Weekly

XLV gained 113bps last week, making a new all-time high for a third straight week. Though the sector is extended, we continue to
recommend an overweight sector positioning given its RS line is holding steady with ideas continuing to act well. Look for immediate
support at the 21-DMA ($153.31), should a pullback occur.